Contribution: Industrial Research Assistance Program – Contributions to Firms
Somru BioScience Inc.
$418,486.00
Development of Novel Chicken antibody Platform for Therapeutic Purposes
FY 2019-20 · 2020-01-22
Summary
Somru BioScience Inc. intends to develop fully integrated therapeutic antibody discovery platform that allows us to unlock complex targets and enable discovery of novel and rare antibodies with therapeutic potential.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Charlottetown|Charlottetown, Prince Edward Island, Canada
Recipient Type
For-profit organization
Business Number
806733887
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-01-22 | 2019-20 | $404,263.00 |
| 1 | 2020-01-22 | 2019-20 | $383,486.00 |
| 2 | 2020-01-22 | 2019-20 | $418,486.00 |
| 3 | 2020-01-22 | 2019-20 | $418,486.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 59 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 59 jours.
Agreement End Date
2022-02-28
Agreement Number
942027
Agreement Start Date
2020-01-22
Agreement Title
Development of Novel Chicken antibody Platform for Therapeutic Purposes
Agreement Title (French)
Mise au point d'une plateforme de nouveaux anticorps de poulet à des fins thérapeutiques
Agreement Type
Contribution
Agreement Value
$418,486.00
Amendment Date
2022-01-28
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Somru BioScience Inc. intends to develop fully integrated therapeutic antibody discovery platform that allows us to unlock complex targets and enable discovery of novel and rare antibodies with therapeutic potential.
Description (French)
Somru BioScience Inc. a l'intention de mettre au point une plateforme de découverte d'anticorps thérapeutiques entièrement intégrée qui nous permettra de débloquer des cibles complexes et de découvrir des anticorps nouveaux et rares disposant d'un potentiel thérapeutique.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Charlottetown
Federal Riding (French)
Charlottetown
Federal Riding Number
11002
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
806733887
Recipient City
Charlottetown|Charlottetown
Recipient Country
CA
Recipient Legal Name
Somru BioScience Inc.
Recipient Postal Code
C1E 0B7
Recipient Province or Territory
PE
Recipient Type
F
Reference Number
172-2019-2020-Q4-942027
